Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative warfarin re-commencement loading dose trial
ACTRN12613001376730Phase 4Not yet recruiting
- Sponsor
- Flinders Medical Centre
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in Conditions requiring chronic anticoagulation, sponsored by Flinders Medical Centre. Primary endpoint: Time to achieve a stable therapeutic INR. Planned start May 2014; status: not yet recruiting.
02
Drugs
warfarin
03
Conditions
Conditions requiring chronic anticoagulation
Beyond the preview
Go deeper on ACTRN12613001376730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001376730.